The Experts below are selected from a list of 18 Experts worldwide ranked by ideXlab platform

Tony Beargie - One of the best experts on this subject based on the ideXlab platform.

Mantu Kumar Satyam - One of the best experts on this subject based on the ideXlab platform.

Glenn Hess - One of the best experts on this subject based on the ideXlab platform.

  • pharma wins in health reform legislation industry to pick up millions of newly insured customers
    Chemical & Engineering News, 2010
    Co-Authors: Glenn Hess
    Abstract:

    THE PHARMACEUTICAL and biotechnology industries are among the victors in the landmark health care reform package (H.R. 3590) signed into law by President Barack Obama last week. “Overall, there is a strong belief that the pharmaceutical industry will benefit from the reform,” says Tijana Ignjatovic, a health care analyst at market analysis firm Datamonitor. Over the next decade, the law will cost drug companies $85 billion in the form of industry surcharges and lower prices they will receive from government programs. But drugmakers ultimately stand to gain when more than 30 million previously uninsured patients begin visiting doctors and using prescription medicines. “Throughout this long process, we have been guided by a belief that all Americans should have access to high-quality, affordable health care coverage and services,” said the industry’s main Lobbying Group, Pharmaceutical Research & Manufacturers of America, in a statement. “This legislation, while not perfect, is a step in that direction.” ...

Alan Dove - One of the best experts on this subject based on the ideXlab platform.

  • business Group presses for broader release of scientific data
    Nature Medicine, 2000
    Co-Authors: Alan Dove
    Abstract:

    The US Chamber of Commerce, a major business Lobbying Group, has begun mounting a challenge to new rules by the White House Office of Management and Budget (OMB), asserting that the OMB undermined a law designed to release research data to the public. The move is the latest volley in an ongoing controversy about the new law, which subjects raw data from many types of clinical and environmental studies to disclosure under the Freedom of Information Act (FOIA).

Kim Bartel Sheehan - One of the best experts on this subject based on the ideXlab platform.

  • this ain t your daddy s greenwashing an assessment of the american petroleum institute s power past impossible campaign
    2018
    Co-Authors: Kim Bartel Sheehan
    Abstract:

    After the Obama administration signed the Paris Agreement to limit emissions, the American Petroleum Institute, a Lobbying Group for the petroleum industry, created a consumer advertising campaign to promote the different ways that the gas and oil industries benefit U.S. citizens. The advertising campaign debuted in the most-watched television program in United States—the Super Bowl—during a time when the U.S. public held strongly different opinions on U.S. Energy policy from the incoming Trump administration and Republican-dominated Congress. Generally, citizens favor investment in renewable energy while the government favors expansion of oil and gas drilling. The American Petroleum Institute campaign attempts to persuade U.S. citizens that the petroleum industry can help U.S. citizens to ‘power past impossible’ and live better lives. This chapter evaluates whether these ads can be considered greenwashing, defined as to the use of messages with environmentalism or green credentials to suggest that a company’s policies and products are environmentally friendly. The Power Past Impossible campaign provides evidence of greenwashing through both explicit communications (such as unsubstantiated claims that ‘gas comes cleaner’ and ‘oil runs cleaner’) and implicit communications (the use of green imagery). The ads also conflate the benefits of innovative products made with petroleum and the production of these products, providing a halo effect that can be misleading.